Pharma Focus Asia

Citrine Medicine and Sinopharm Group Announce Strategic Partnership to Broaden and Accelerate Access to Rare Disease Drugs in China

Tuesday, April 20, 2021

Citrine Medicine, a China-based rare disease therapeutics company, and Sinopharm Group, a Chinese pharmaceutical company, announced a strategic partnership to accelerate the commercialization of rare disease drugs in China. The two companies will work together to build a rare disease ecosystem in China and enable the availability of more rare disease therapies to Chinese patients in need.

As part of the collaboration, Sinopharm Group will support Citrine in building a supply chain and securing distribution channels for delivering innovative rare disease therapies to patients in need. Sinopharm Group has more than 1,000 branches and subsidiaries, covering 388 prefecture-level cities in 31 provinces in China, enabling the company to reach patients in urban and rural regions across China.

"We are very excited to launch this new strategic partnership with Citrine Medicine," said Yong Liu, President of Sinopharm Group. "As a leading biopharmaceutical company in China, Citrine Medicine is working to introduce multiple innovative drugs to serve patients with rare diseases. Sinopharm Group will leverage our knowledge and our connections within China's drug development supply chain to support Citrine in accelerating the pace at which we can bring new therapies to patients who need them."

"This new partnership with Sinopharm Group brings us closer to our vision of creating the very first rare disease ecosystem for patients in China," said Melissa Bradford-Klug, President and Chief Business Officer of Citrine. "By working with Sinopharm, we will strengthen our relationships with strategic partners across China, including state-run distribution networks, enabling us to more rapidly bring more first- and best-in-class breakthrough therapies to the approximately 20 million patients with rare diseases living in China."

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024ISPE Singapore Affiliate Conference & Exhibition 2024Rehab Expo 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024